Navigation Links
New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System
Date:5/21/2013

SAN FRANCISCO, May 21, 2013 /PRNewswire/ -- New data released today at the annual meeting of the American Psychiatric Association show that the NeuroStar TMS Therapy System® induced statistically and clinically meaningful response and remission in patients with Major Depressive Disorder (MDD) during the acute phase of therapy, which were maintained through one year of treatment.  At the end of acute treatment, 62 percent of patients achieved symptomatic improvement while 41 percent reported complete remission. At 12 months, 68 percent of patients achieved symptomatic improvement while 45 percent reported complete remission. Maintenance of benefit was observed under a pragmatic regimen of continuation antidepressant medication and access to TMS reintroduction for symptom recurrence.

"The durability of NeuroStar TMS Therapy demonstrated by this robust, real-world study is remarkable, as it's not typical to see long-term benefit in patients who have treatment resistant forms of depression," said Dr. Philip Janicak , M.D., Professor of Psychiatry at Rush University, and Medical Director of the Rush Psychiatric Clinical Research Center. "The study reinforces the sustained efficacy of NeuroStar TMS Therapy in a majority of patients with depression who have not found relief through oral antidepressant medication."

With 42 clinical practices participating, 307 patients with a primary diagnosis of unipolar, non-psychotic major depressive disorder, who had failed to receive benefit from prior antidepressant medication, received NeuroStar TMS Therapy.

The objectives of this study were to assess the change in depressive symptomatology and functional capacities across the duration of acute and long-term follow-up treatment with NeuroStar TMS. Of the patient population, 257 patients received benefit with acute TMS treatment, then were tapered from their acute treatment regimen a
'/>"/>

SOURCE Neuronetics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
2. Varicella Vaccine has Long-Term Effectiveness Against Chicken Pox
3. Can Hormone Help Treat Multiple Sclerosis Long-Term?
4. AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation
5. The Emirate of Abu Dhabi Becomes First to Have JCI Accredited Long-Term Care Facility Outside of USA
6. Amgen Outlines Long-Term Strategy
7. New Long-Term Study Suggests Lower Mortality in Alzheimers Patients Treated with Galantamine Versus Placebo
8. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
9. Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen
10. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
11. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Critical Process Filtration, ... , today announces the expansion of their Technical ... Process Filtration now offers customers and potential customers ... to filter failure analyses (even for competitor filters) ... their hallmark services of system benchmarking and cost/performance ...
(Date:8/28/2014)... -- Rx Safes, Inc., the manufacturer of fingerprint recognition home ... new war on drugs to reduce prescription drug abuse, ... than 2,500 children a day experiment with prescription drugs ... accessed from unsecured medicine cabinets, closets and drawers.  While law ... Safes will address the new age drug dealer in ...
(Date:8/28/2014)... , Californie, 28 août 2014 ... annoncé aujourd,hui le début des inclusions ... étude  d,exemption des dispositifs expérimentaux (ou ... à évaluer l,innocuité et l,efficacité du ... Le docteur Adam Arthur , ...
Breaking Medicine Technology:Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support 2Rx Safes, Inc. Announces New War On Drugs 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4
... 1, 2011 Hologic, Inc. (Hologic or ... developer, manufacturer and supplier of premium diagnostics, medical imaging ... needs of women, today announced it has acquired TCT ... in China, including Hologic,s ThinPrep Pap Test, related instruments ...
... Technology makes the PROFIT 200 list for the third ... Technology, headquartered in Toronto, has been included in the ... by PROFIT Magazine. Ranking Canada,s Fastest-Growing Companies by five-year ... successful growth companies. Published in the Summer issue of ...
Cached Medicine Technology:Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 2Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 3Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 4Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China 5Claron Technology Makes the PROFIT 200 List for the Third Consecutive Year 2
(Date:8/28/2014)... Commercial growers all over the continent are waitlisted ... grow lights, which perform on par with 1000w HPS at ... lighting needs no cooling equipment and does not overheat the ... Factoring in that they never need bulbs changed, the internal ... year. , For many indoor growers, cooler room temperatures also ...
(Date:8/28/2014)... be given to healthy volunteers in the UK, The ... of an series of safety trials of potential vaccines ... than 1,400 people in the current outbreak in West ... co-developed by the US National Institutes of Health (NIH) ... an international consortium in response to the Ebola epidemic, ...
(Date:8/28/2014)... place glue directly on the nerve stumps, but this ... allows glue to easily invade the nerve ends. Ordinarily, ... insert the nerve ends into the conduit because the ... Liang and co-workers from the General Hospital of Chinese ... and defined the best parameters for its use through ...
(Date:8/28/2014)... of patients with stage III colon cancer had improved ... a new study in Gastroenterology ... Association. , When added to the standard chemotherapy treatment ... overall survival rates for patients with the CpG island ... to 20 percent of colorectal cancers. Patients with CIMP-negative ...
(Date:8/28/2014)... in the study who were on a class of ... as prescribed in the first six months. Patients from ... around the UK involved in the study. , Researchers ... Genomics at The University of Manchester, who led the ... known as ,non-adherence, reduced their effectiveness and may lead ...
Breaking Medicine News(10 mins):Health News:New Kind K5 Series LED Grow Lights Pave Way for Future of Indoor Gardening 2Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:Drug shows promise for subset of stage III colon cancer patients 2Health News:Arthritis patients failing to take expensive medication, according to new research 2
... substantially reduce the risk of ovarian cancer in women ... research. Researchers say the magnitude of the risk reduction ... cancer has the highest fatality rate of all gynecological ... the strong predictors of developing ovarian cancer is a ...
... said on Thursday they were combining two new and experimental ... try to treat muscular dystrophy. Their early work has shown ... is years away. ,Writing in the journal Science, the ... Research Institute in Milan and the University of Rome said ...
... (GH) replacement therapy dosed to normalize IGF-I levels may be ... weight loss program for obese adults. ,The goal of ... retain lean body mass such as muscle,but what happens is ... they stop losing weight. Low levels of GH, known to ...
... rays -- two of which can cause severe skin ... Services at the University of California, the most dangerous ... shorter wavelengths and are primarily responsible for sunburn. Repeated ... immune system and can lead to melanoma and basal ...
... care what the compound microscope was to the biology ... worn on the body, such as a band around ... includes time spent lying down or sleeping, time spent ... ,Few medical advances in recent decades have had ...
... on Friday it expected to announce the removal of the island ... countries where new cases of the deadly virus had been reported ... the disease is 10 days, and twice that time is the ... situation over. ,The move, due to be announced at a ...
Cached Medicine News:Health News:Stem cells offer hope for muscular dystrophy 2Health News:Low-dose Growth Hormone (GH) with diet and exercise may help weight loss 2Health News:SARS-Free Taiwan to Mark End Phase of Global Fight 2
... Single use curved circular ... and titanium staples., ,The ... stapler is used throughout the ... of end-to-end, end-to-side and side-to-side ...
... The Scantibodies Calcitonin Immunoassay is a two-site ... calcitonin. Two different goat polyclonal antibodies to ... chromatography to be specific for well-defined regions ... quantitative determination of Calcitonin in human serum. ...
Calcitonin RIA Kit...
... IMAGE1 is the first completely digital camera ... in the field of endoscopic camera systems. ... the first time, facilitates the fully digital ... quality using an A/D converter, as well ...
Medicine Products: